Rhone-poulenc Rorer S.a.

Aventis Behring Gmbh

Novozymes Biopharma UK Limited

Other

Rhone-poulenc, Inc.

Novozymes Biopharma Dk A/s

Reinhard Fleer

Patrice Yeh

Alain Fournier

Jean-Dominique Guitton

Gérard Jung

Daniel Scherman

David Klatzmann

Claudio Falcone

Jean-Francois Mayaux

Christophe Marcireau

Jean-Francedillaois Mayaux

Gerard Jung

Widmar Tanner

Sabine Strahl-Bolsinger

J Er Becquart

G Erard Jung

Michele Saliola

Didier Landais

Philippe Hirel

Jerome Becquart

G&eacute;rard Jung

Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant of human serum albumin, methods for preparation, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing fusion polypeptides.

Methods of treating using hormone-albumin fusion proteins

Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.

Methods of treatment with interferson and albumin fusion protein

The invention includes biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant of human serum albumin, methods for the preparation of such fusion polypeptides, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing such fusion polypeptides.

Fusion polypeptides of human serum albumin and a therapeutically active polypeptide

Insulin and albumin fusion protein

Interleukin and albumin fusion protein

Hormone and albumin fusion protein

G-CSF and albumin fusion protein

Methods of treatment with erythropoietin and albumin fusion protein

Erythropoietin and albumin fusion protein, nucleic acids, and methods thereof

Interferon and albumin fusion protein

Utilization of albumin as a stable plasma transporter with a therapeutic function that is derived from a membrane receptor. The present invention is exemplified by the description of new therapeutic agents that can be used in the treatment of Acquired Immunodeficiency Syndrome: hybrid macromolecules composed of albumin derivatives coupled to derivatives of the CD4 receptor having a normal or a higher affinity for the HIV-1 virus.

Albumin derivatives with therapeutic functions

Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a natural variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.

Fusion polypeptides comprising human serum albumin, nucleic acids

Yeast with modified permeability

Modified fungal cells and method for producing recombinant products

Growing community of inventors

Bures-sur-Yvette, France

Reinhard Fleer